The artificial intelligence giant OpenAI announced it has acquired Orchestra Bio, a startup that builds AI agents to help pharmaceutical companies manage drug development, the company told Axios.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.